Vaxcyte (PCVX) Common Equity (2019 - 2026)
Vaxcyte (PCVX) recorded Common Equity of $2.76 billion in Q2 2026, down 10.2% from $3.07 billion a year earlier and down 7.9% from the prior quarter.
Powered by 
Analysis
Vaxcyte (PCVX) Common Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, Vaxcyte reported Common Equity of $2.69 billion, down 18.8% from FY2024.
- Annual Common Equity has a five-year compound annual growth rate of 50.7% (FY2020 to FY2025).
- Across earlier years, Common Equity came in at $3.31 billion in FY2024 (+166.5%), $1.24 billion in FY2023 (+30.1%), $953.61 million in FY2022 (+235.8%) and $284.02 million in FY2021 (-17.9%).
- Quarterly Common Equity has ranged from $284.02 million in Q4 2021 to $3.42 billion in Q3 2024 over the past five years.
- On a year-over-year basis, Common Equity has declined for four consecutive quarters, with growth averaging 46.9% over the last eight quarters.
- Peak year-over-year performance for Common Equity in the last five years was growth of 291.1% in Q2 2023, against a decline of 18.8% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $3 billion (Q1 2026), $2.69 billion (Q4 2025) and $2.89 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Vaxcyte | 8.44 Bn | 8.44 Bn | - | 2.76 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.76 Bn |
| Mar 31, 2026 | 3.00 Bn |
| Dec 31, 2025 | 2.69 Bn |
| Sep 30, 2025 | 2.89 Bn |
| Jun 30, 2025 | 3.07 Bn |
| Mar 31, 2025 | 3.20 Bn |
| Dec 31, 2024 | 3.31 Bn |
| Sep 30, 2024 | 3.42 Bn |
| Jun 30, 2024 | 1.99 Bn |
| Mar 31, 2024 | 1.98 Bn |
| Dec 31, 2023 | 1.24 Bn |
| Sep 30, 2023 | 1.40 Bn |
| Jun 30, 2023 | 1.43 Bn |
| Mar 31, 2023 | 944.77 Mn |
| Dec 31, 2022 | 953.61 Mn |
| Sep 30, 2022 | 359.31 Mn |
| Jun 30, 2022 | 366.50 Mn |
| Mar 31, 2022 | 359.54 Mn |
| Dec 31, 2021 | 284.02 Mn |
| Sep 30, 2021 | 305.96 Mn |
API Access
Vaxcyte Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=PCVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "PCVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=PCVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();